FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Antonio Santillan-Gomez

Research Profile

Disorders

Concepts & Ideas

Activities & Behaviors

Cost Benefit Analysis

Procedures

Physiology

Cell Proliferation

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Giovanni D Aletti; Eric L Eisenhauer; Antonio Santillan-Gomez; Allison Axtell; Giacomo Aletti; Christine H Holschneider; Dennis S Chi; Robert E Bristow; William A Cliby
Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment.
Edward J Tanner; Dennis S Chi; Eric L Eisenhauer; Teresa P Diaz-Montes; Antonio Santillan-Gomez; Robert E Bristow
Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?
Katherine Goodrich Kratz; Antonio Santillan-Gomez; Mai Gu; Robert E Bristow
Radical surgical cytoreduction of progressive leiomyomatosis peritonealis disseminata: a case report.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Antonio Santillan-Gomez (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Giovanni D Aletti; Eric L Eisenhauer; Antonio Santillan-Gomez; Allison Axtell; Giacomo Aletti; Christine H Holschneider; Dennis S Chi; Robert E Bristow; William A Cliby
Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment.
Gynecologic oncology 2011;120(1):23-8.
2010: Edward J Tanner; Dennis S Chi; Eric L Eisenhauer; Teresa P Diaz-Montes; Antonio Santillan-Gomez; Robert E Bristow
Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?
Gynecologic oncology 2010;117(2):336-40.
2009: Katherine Goodrich Kratz; Antonio Santillan-Gomez; Mai Gu; Robert E Bristow
Radical surgical cytoreduction of progressive leiomyomatosis peritonealis disseminata: a case report.
The Journal of reproductive medicine 2009;54(7):447-50.
2009: Miyun Tsai-Turton; Antonio Santillan-Gomez; Dan Lu; Robert E Bristow; Kwun C Chan; Ie-Ming Shih; Richard B S Roden
p53 autoantibodies, cytokine levels and ovarian carcinogenesis.
Gynecologic oncology 2009;114(1):12-7.
2008: Martina Bazzaro; Zhenhua Lin; Antonio Santillan-Gomez; Michael K Lee; Mei-Cheng Wang; Kwun C Chan; Robert E Bristow; Ralph Mazitschek; James Bradner; Richard B S Roden
Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7340-7.
2008: Antonio Santillan-Gomez; Linda Govan; Marianna Zahurak; Teresa P Diaz-Montes; Robert L Giuntoli; Robert E Bristow
Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice.
Gynecologic oncology 2008;109(3):388-93.
2008: Melissa A Gerardi; Antonio Santillan-Gomez; Benjamin Meisner; Marianna Zahurak; Teresa P Diaz-Montes; Robert L Giuntoli; Robert E Bristow
A clinical pathway for patients undergoing primary cytoreductive surgery with rectosigmoid colectomy for advanced ovarian and primary peritoneal cancers.
Gynecologic oncology 2008;108(2):282-6.
2007: Ritu Salani; Marianna Zahurak; Antonio Santillan-Gomez; Robert L Giuntoli; Robert E Bristow
Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study.
Gynecologic oncology 2007;107(3):495-9.
2007: Martina Bazzaro; Antonio Santillan-Gomez; Zhenhua Lin; Taylor Tang; Michael K Lee; Robert E Bristow; Ie-Ming Shih; Richard B S Roden
Myosin II co-chaperone general cell UNC-45 overexpression is associated with ovarian cancer, rapid proliferation, and motility.
The American journal of pathology 2007;171(5):1640-9.
2007: Giacomo Aletti; Antonio Santillan-Gomez; Eric L Eisenhauer; Jae Hu; Giacomo Aletti; Karl C Podratz; Robert E Bristow; Dennis S Chi; William A Cliby
A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model.
Gynecologic oncology 2007;107(1):99-106.
2007: Robert E Bristow; Antonio Santillan-Gomez; Ritu Salani; Teresa P Diaz-Montes; Robert L Giuntoli; Benjamin C Meisner; Deborah K Armstrong; Kevin D Frick
Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis.
Gynecologic oncology 2007;106(3):476-81.
2007: Antonio Santillan-Gomez; Y W Kim; Marianna Zahurak; Ginger J Gardner; Robert L Giuntoli; Ie-Ming Shih; Robert E Bristow
Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(3):601-6.
2007: Robert E Bristow; Antonio Santillan-Gomez; Teresa P Diaz-Montes; Ginger J Gardner; Robert L Giuntoli; Benjamin C Meisner; Kevin D Frick; Deborah K Armstrong
Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis.
Cancer 2007;109(8):1513-22.
2007: Antonio Santillan-Gomez; Amer Karam; Andrew J Li; Robert L Giuntoli; Ginger J Gardner; Ilana Cass; Beth Y Karlan; Robert E Bristow
Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
Gynecologic oncology 2007;104(3):686-90.
2007: Robert E Bristow; Antonio Santillan-Gomez; Teresa P Diaz-Montes; Ginger J Gardner; Robert L Giuntoli; Susan T Peeler
Prevention of adhesion formation after radical hysterectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier: a cost-effectiveness analysis.
Gynecologic oncology 2007;104(3):739-46.
2007: Ritu Salani; Antonio Santillan-Gomez; Marianna Zahurak; Robert L Giuntoli; Ginger J Gardner; Deborah K Armstrong; Robert E Bristow
Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome.
Cancer 2007;109(4):685-91.
2007: Robert E Bristow; Eric L Eisenhauer; Antonio Santillan-Gomez; Dennis S Chi
Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction.
Gynecologic oncology 2007;104(2):480-90.
2007: Amer Karam; Antonio Santillan-Gomez; Robert E Bristow; Robert L Giuntoli; Ginger J Gardner; Ilana Cass; Beth Y Karlan; Andrew J Li
Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome.
Gynecologic oncology 2007;104(2):377-80.
2006: Kentaro Nakayama; Naomi Nakayama; Ben Davidson; Jim Jinn-Chyuan Sheu; Natini Jinawath; Antonio Santillan-Gomez; Ritu Salani; Robert E Bristow; Patrice J Morin; Robert J Kurman; Tian-Li Wang; Ie-Ming Shih
A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(49):18739-44.
2006: Robert E Bristow; Scott C Purinton; Antonio Santillan-Gomez; Teresa P Diaz-Montes; Ginger J Gardner; Robert L Giuntoli
Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance.
Gynecologic oncology 2006;103(2):709-13.
2006: Robert E Bristow; Antonio Santillan-Gomez; Marianna Zahurak; Ginger J Gardner; Robert L Giuntoli; Deborah K Armstrong
Salvage cytoreductive surgery for recurrent endometrial cancer.
Gynecologic oncology 2006;103(1):281-7.
2006: Martina Bazzaro; Michael K Lee; Alessia Zoso; Wanda L H Stirling; Antonio Santillan-Gomez; Ie-Ming Shih; Richard B S Roden
Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosis.
Cancer research 2006;66(7):3754-63.
2006: Antonio Santillan-Gomez; Robert E Bristow
Paraneoplastic cerebellar degeneration in a woman with ovarian cancer.
Nature clinical practice. Oncology 2006;3(2):108-12; quiz 1 p following 112.
2005: Antonio Santillan-Gomez; Ruchi Garg; Marianna Zahurak; Ginger J Gardner; Robert L Giuntoli; Deborah K Armstrong; Robert E Bristow
Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9338-43.
2005: Ie-Ming Shih; Jim Jinn-Chyuan Sheu; Antonio Santillan-Gomez; Kentaro Nakayama; M Jim Yen; Robert E Bristow; Russell Vang; Giovanni Parmigiani; Robert J Kurman; Claes G Trope; Ben Davidson; Tian-Li Wang
Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(39):14004-9.
2003: Antonio Santillan-Gomez; Alberto Montero; John J Kavanagh; Jinsong Liu; Pedro T Ramirez
Vulvar Langerhans cell histiocytosis: a case report and review of the literature.
Gynecologic oncology 2003;91(1):241-6.